Comparison between the standart α interferon and pegylated interferon in the treatment of chronic hepatitis C pacients
DOI:
https://doi.org/10.5585/conssaude.v6i1.904Keywords:
Interferon convencional. Interferon peguilado. Hepatite C.Abstract
Chronic hepatitis C is a significative world problem, with high economical and social impact. The standard treatment on patients with hepatitis C is made with Interferon a (INFa), which is featured by its fast metabolization and several adverse effects generated by the peaks concentration. An alternative treatment has been developed using pegylated interferons (PEG INF), with a better pharmacokinetics and a weekly scheme of administration, thus offering the patients a higher chance of cure. PEG INF also reduces the incidence of side effects, usually associated to the conventional treatment, improving the capacity of the patients to tolerate and continue the treatment.Downloads
Download data is not yet available.
Downloads
Published
2008-04-07
How to Cite
1.
Bezerra CA, Oliveira JS de. Comparison between the standart α interferon and pegylated interferon in the treatment of chronic hepatitis C pacients. Cons. Saúde [Internet]. 2008 Apr. 7 [cited 2024 Sep. 26];6(1):19-28. Available from: https://periodicos.uninove.br/saude/article/view/904
Issue
Section
Artigos
License
Copyright (c) 2007 ConScientiae Saúde
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.